{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:52:03Z","timestamp":1792155123800,"version":"4.4.0"},"reference-count":39,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Dent Res"],"abstract":"<jats:p>GLP-1RAs (glucagon-like peptide-1 receptor agonists) have become one of the fastest-growing drug classes worldwide, with prescriptions for obesity treatment increasing by 587% from 2019 to 2024. While their metabolic and cardiovascular benefits are well established, the implications for oral health remain largely unexamined. Preclinical evidence consistently demonstrates anti-inflammatory and osteoprotective effects on periodontal and peri-implant tissues: GLP-1RAs promote osteogenic differentiation of periodontal ligament stem cells, reduce alveolar bone resorption in animal models of periodontitis, and enhance implant osseointegration in diabetic rats. However, these findings are based exclusively on in vitro and animal studies, with only a single retrospective cohort study providing limited clinical data. Conversely, several oral adverse effects have been reported based on pharmacovigilance analyses, including xerostomia, dysgeusia, and anosmia, particularly for semaglutide. Gastrointestinal side effects, particularly nausea (15% to 50%), vomiting (5% to 24%), and gastroesophageal reflux, pose a plausible but unquantified risk for tooth erosion and secondary caries. A bidirectional link between GLP-1 signaling and the oral microbiota, mediated by bacterial dipeptidyl peptidase (DPP)\u20134\u2013like enzymes that degrade endogenous GLP-1, adds further complexity. Despite this breadth of potential interactions, no prospective study has used any dental outcome as an endpoint in patients receiving GLP-1RAs. This critical appraisal synthesizes the evidence across multiple dental disciplines, grades it in each domain, and identifies the gaps that demand urgent investigation.<\/jats:p>","DOI":"10.1177\/00220345261488338","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:48:21Z","timestamp":1791989301000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 Receptor Agonists in Dentistry: Promise, Pitfalls, and Evidence Gaps"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8498-0736","authenticated-orcid":false,"given":"N.","family":"Werner","sequence":"first","affiliation":[{"name":"Department of Conservative Dentistry, Periodontology and Digital Dentistry, LMU University Hospital, LMU Medizin, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6947-2602","authenticated-orcid":false,"given":"V.","family":"Pitchika","sequence":"additional","affiliation":[{"name":"Department of Conservative Dentistry, Periodontology and Digital Dentistry, LMU University Hospital, LMU Medizin, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.V.","family":"Bumm","sequence":"additional","affiliation":[{"name":"Department of Conservative Dentistry, Periodontology and Digital Dentistry, LMU University Hospital, LMU Medizin, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2273-3662","authenticated-orcid":false,"given":"K.","family":"Heck","sequence":"additional","affiliation":[{"name":"Department of Conservative Dentistry, Periodontology and Digital Dentistry, LMU University Hospital, LMU Medizin, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Folwaczny","sequence":"additional","affiliation":[{"name":"Department of Conservative Dentistry, Periodontology and Digital Dentistry, LMU University Hospital, LMU Medizin, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1223-1669","authenticated-orcid":false,"given":"F.","family":"Schwendicke","sequence":"additional","affiliation":[{"name":"Department of Conservative Dentistry, Periodontology and Digital Dentistry, LMU University Hospital, LMU Medizin, LMU Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","unstructured":"Akakura M Watari I Watanabe M Jiratchaya S Ono T. 2024. Expression of glucagon-like peptide-1 receptors in the submandibular gland of mice and its implications in type 2 diabetes. Cureus. 16(9):e70465. https:\/\/doi.org\/10.7759\/cureus.70465","DOI":"10.7759\/cureus.70465"},{"key":"e_1_3_4_3_1","doi-asserted-by":"crossref","unstructured":"Bara\u0107 M Roganovi\u0107 J. 2025. GLP-1 receptor signaling and oral dysfunction: a narrative review on the mechanistic basis of semaglutide-related oral adverse effects. Biology. 14(12):1650. https:\/\/doi.org\/10.3390\/biology14121650","DOI":"10.3390\/biology14121650"},{"key":"e_1_3_4_4_1","doi-asserted-by":"crossref","unstructured":"Celletti F Farrar J De Regil L. 2026. World Health Organization guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults. JAMA. 335(5):434\u2013438. https:\/\/doi.org\/10.1001\/jama.2025.24288","DOI":"10.1001\/jama.2025.24288"},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","unstructured":"Chakraborty A Anjankar AP. 2022. Association of gastroesophageal reflux disease with dental erosion. Cureus. 14(10):e30381. https:\/\/doi.org\/10.7759\/cureus.30381","DOI":"10.7759\/cureus.30381"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","unstructured":"Chen H et al. 2025. Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System. Sci Rep. 15(1):18063. https:\/\/doi.org\/10.1038\/s41598-025-01206-9","DOI":"10.1038\/s41598-025-01206-9"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","unstructured":"Chen Z et al. 2024. Role of LRP5\/6\/GSK-3\u03b2\/\u03b2-catenin in the differences in exenatide- and insulin-promoted T2D osteogenesis and osteomodulation. Br J Pharmacol. 181(19):3556\u20133575. https:\/\/doi.org\/10.1111\/bph.16421","DOI":"10.1111\/bph.16421"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","unstructured":"Drucker DJ. 2022. GLP-1 physiology informs the pharmacotherapy of obesity. Mol Metab. 57:101351. https:\/\/doi.org\/10.1016\/j.molmet.2021.101351","DOI":"10.1016\/j.molmet.2021.101351"},{"key":"e_1_3_4_9_1","unstructured":"FAIR Health. 2025. Obesity and GLP-1 drugs: a claims-based analysis. FAIR Health Inc. https:\/\/s3.amazonaws.com\/media2.fairhealth.org\/whitepaper\/asset\/Obesity%20and%20GLP-1%20Drugs%20-%20A%20FAIR%20Health%20White%20Paper.pdf"},{"key":"e_1_3_4_10_1","doi-asserted-by":"crossref","unstructured":"Guo Z Chen R Zhang F Ding M Wang P. 2018. Exendin-4 relieves the inhibitory effects of high glucose on the proliferation and osteoblastic differentiation of periodontal ligament stem cells. Arch Oral Biol. 91:9\u201316. https:\/\/doi.org\/10.1016\/j.archoralbio.2018.03.014","DOI":"10.1016\/j.archoralbio.2018.03.014"},{"key":"e_1_3_4_11_1","doi-asserted-by":"crossref","unstructured":"Iyer S Montmayeur J-P Zolotukhin S Dotson CD. 2025. Exogenous oral application of PYY and exendin-4 impacts upon taste-related behavior and taste perception in wild-type mice. Neuropharmacology. 272:110408. https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110408","DOI":"10.1016\/j.neuropharm.2025.110408"},{"key":"e_1_3_4_12_1","doi-asserted-by":"crossref","unstructured":"Jeong N Chuang L-H Ho Y. 2025. Periodontitis and GLP-1 pathways: a new frontier in oral-systemic health connections\u2014a scoping review. Front Clin Diabetes Healthc. 6:1679511. https:\/\/doi.org\/10.3389\/fcdhc.2025.1679511","DOI":"10.3389\/fcdhc.2025.1679511"},{"key":"e_1_3_4_13_1","doi-asserted-by":"crossref","unstructured":"Jung J-E Park S-B Yu HY Yoon S-B Kim J. 2026. Amelioration of D-galactose-induced hyposalivation in aging rats by the GLP-1 receptor agonist Exendin-4. Eur J Pharmacol. 1011:178445. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178445","DOI":"10.1016\/j.ejphar.2025.178445"},{"key":"e_1_3_4_14_1","doi-asserted-by":"crossref","unstructured":"Khan FI et al. 2025. Otolaryngologic side effects of GLP-1 receptor agonists. Laryngoscope. 135(7):2291\u20132298. https:\/\/doi.org\/10.1002\/lary.32061","DOI":"10.1002\/lary.32061"},{"key":"e_1_3_4_15_1","doi-asserted-by":"crossref","unstructured":"Lee AA et al. 2025. Incretin-based therapies through the decades: molecular innovations and clinical impact. Med Sci (Basel). 13(4):269. https:\/\/doi.org\/10.3390\/medsci13040269","DOI":"10.3390\/medsci13040269"},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","unstructured":"Li J et al. 2026. Injectable Schiff base-engineered hydrogel for spatiotemporal liraglutide delivery orchestrates diabetic periodontitis regression via multimodal microenvironment reprogramming. J Control Release. 392:114688. https:\/\/doi.org\/10.1016\/j.jconrel.2026.114688","DOI":"10.1016\/j.jconrel.2026.114688"},{"key":"e_1_3_4_17_1","doi-asserted-by":"crossref","unstructured":"Liang Q Du L Zhang R Kang W Ge S. 2021. Stromal cell-derived factor-1\/exendin-4 cotherapy facilitates the proliferation migration and osteogenic differentiation of human periodontal ligament stem cells in vitro and promotes periodontal bone regeneration in vivo. Cell Prolif. 54(3):e12997. https:\/\/doi.org\/10.1111\/cpr.12997","DOI":"10.1111\/cpr.12997"},{"key":"e_1_3_4_18_1","doi-asserted-by":"crossref","unstructured":"Lin J et al. 2023. Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014\u20132022). Eur J Clin Pharmacol. 79(9):1239\u20131248. https:\/\/doi.org\/10.1007\/s00228-023-03539-8","DOI":"10.1007\/s00228-023-03539-8"},{"key":"e_1_3_4_19_1","doi-asserted-by":"crossref","unstructured":"Lincoff AM et al. 2023. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 389(24):2221\u20132232. https:\/\/doi.org\/10.1056\/nejmoa2307563","DOI":"10.1056\/NEJMoa2307563"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","unstructured":"Liu H Zheng J Zheng T Wang P. 2019. Exendin-4 regulates Wnt and NF-\u03baB signaling in lipopolysaccharide-induced human periodontal ligament stem cells to promote osteogenic differentiation. Int Immunopharmacol. 75:105801. https:\/\/doi.org\/10.1016\/j.intimp.2019.105801","DOI":"10.1016\/j.intimp.2019.105801"},{"key":"e_1_3_4_21_1","doi-asserted-by":"crossref","unstructured":"Liu Z et al. 2015. Potential mechanism for osseointegration of dental implants in Zucker diabetic fatty rats. Br J Oral Maxillofac Surg. 53(8):748\u2013753. https:\/\/doi.org\/10.1016\/j.bjoms.2015.05.023","DOI":"10.1016\/j.bjoms.2015.05.023"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","unstructured":"Mawardi HH et al. 2023. Semaglutide-associated hyposalivation: a report of case series. Medicine (Baltimore). 102(52):e36730. https:\/\/doi.org\/10.1097\/md.0000000000036730","DOI":"10.1097\/MD.0000000000036730"},{"key":"e_1_3_4_23_1","doi-asserted-by":"crossref","unstructured":"McKenzie C DeBernardo A Schwartz P. 2025. Implications of GLP-1 agonists on office-based sedation and general anesthesia for dentistry. Anesth Prog. 72(1):52\u201358. https:\/\/doi.org\/10.2344\/anpr-72-1-anpr_agonists","DOI":"10.2344\/anpr-72-1-ANPR_Agonists"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","unstructured":"Nagi R Kumar SS Sheth M Deshpande A Khan J. 2025. Association between oral microbiome dysbiosis and Sjogren syndrome. A systematic review of clinical studies. Arch Oral Biol. 172:106167. https:\/\/doi.org\/10.1016\/j.archoralbio.2024.106167","DOI":"10.1016\/j.archoralbio.2024.106167"},{"key":"e_1_3_4_25_1","doi-asserted-by":"crossref","unstructured":"Nakamura H et al. 2023. Lysosome-associated membrane protein 3 induces lysosome-dependent cell death by impairing autophagic caspase 8 degradation in the salivary glands of individuals with Sj\u00f6gren\u2019s disease. Arthritis Rheumatol. 75(9):1586\u20131598. https:\/\/doi.org\/10.1002\/art.42540","DOI":"10.1002\/art.42540"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","unstructured":"O\u2019Driscoll J McIntyre G. 2026. Glucagon-like peptide-1 receptor agonists: a review of the literature from a dental perspective. Br Dent J. 240(3):144\u2013148. https:\/\/doi.org\/10.1038\/s41415-025-9345-4","DOI":"10.1038\/s41415-025-9345-4"},{"key":"e_1_3_4_27_1","doi-asserted-by":"crossref","unstructured":"Ohara-Nemoto Y et al. 2018. Distribution of dipeptidyl peptidase (DPP) 4 DPP5 DPP7 and DPP11 in human oral microbiota-potent biomarkers indicating presence of periodontopathic bacteria. FEMS Microbiol Lett. 365(22):fny221. https:\/\/doi.org\/10.1093\/femsle\/fny221","DOI":"10.1093\/femsle\/fny221"},{"key":"e_1_3_4_28_1","doi-asserted-by":"crossref","unstructured":"Ohara-Nemoto Y et al. 2022. Expanded substrate specificity supported by P1\u2019 and P2\u2019 residues enables bacterial dipeptidyl-peptidase 7 to degrade bioactive peptides. J Biol Chem. 298(3):101585. https:\/\/doi.org\/10.1016\/j.jbc.2022.101585","DOI":"10.1016\/j.jbc.2022.101585"},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","unstructured":"Ono R. 2015. [GLP-1 receptor expression in rat major salivary glands and the effects of bilateral maxillary molar extraction on its expression]. Kokubyo Gakkai Zasshi. [accessed 2026 May 6] 81(3)-82(1):8\u201314. https:\/\/pubmed.ncbi.nlm.nih.gov\/26043556\/","DOI":"10.5357\/koubyou.81and82.3-1_8"},{"key":"e_1_3_4_30_1","doi-asserted-by":"crossref","unstructured":"Pai S-L et al. 2026. Assessment of gastric content using gastric ultrasound in patients on glucagon-like peptide-1 receptor agonists before anesthesia. Anesth Analg. 142(4):640\u2013649. https:\/\/doi.org\/10.1213\/ane.0000000000007764","DOI":"10.1213\/ANE.0000000000007764"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","unstructured":"Polymeri A Feres M Giannobile WV Loos BG. 2026. GLP-1 receptor agonists: bridging diabetes obesity and periodontitis\u2014a scoping review of emerging evidence. J Periodontol. 97(6):1243\u20131256. https:\/\/doi.org\/10.1002\/jper.70092","DOI":"10.1002\/jper.70092"},{"key":"e_1_3_4_32_1","doi-asserted-by":"crossref","unstructured":"Sanyal AJ et al. 2025. Phase 3 trial of semaglutide in metabolic dysfunction\u2013associated steatohepatitis. N Engl J Med. 392(21):2089\u20132099. https:\/\/doi.org\/10.1056\/nejmoa2413258","DOI":"10.1056\/NEJMoa2413258"},{"key":"e_1_3_4_33_1","doi-asserted-by":"crossref","unstructured":"Sawada N et al. 2020. Glucagon-like peptide-1 receptor agonist liraglutide ameliorates the development of periodontitis. J Diabetes Res. 2020:8843310. https:\/\/doi.org\/10.1155\/2020\/8843310","DOI":"10.1155\/2020\/8843310"},{"key":"e_1_3_4_34_1","doi-asserted-by":"crossref","unstructured":"Shen W-R et al. 2021. Local administration of high-dose diabetes medicine exendin-4 inhibits orthodontic tooth movement in mice. Angle Orthod. 91(1):111\u2013118. https:\/\/doi.org\/10.2319\/021320-103.1","DOI":"10.2319\/021320-103.1"},{"key":"e_1_3_4_35_1","doi-asserted-by":"crossref","unstructured":"Shi S et al. 2021. Clinical and radiographic variables related to implants with simultaneous grafts among type 2 diabetic patients treated with different hypoglycemic medications: a retrospective study. BMC Oral Health. 21(1):214. https:\/\/doi.org\/10.1186\/s12903-021-01583-3","DOI":"10.1186\/s12903-021-01583-3"},{"key":"e_1_3_4_36_1","doi-asserted-by":"crossref","unstructured":"Urbina J Salinas-Ruiz LE Valenciano C Clapp B. 2026. Micronutrient and nutritional deficiencies associated with GLP-1 receptor agonist therapy: a narrative review. Clin Obes. 16(1):e70070. https:\/\/doi.org\/10.1111\/cob.70070","DOI":"10.1111\/cob.70070"},{"key":"e_1_3_4_37_1","doi-asserted-by":"crossref","unstructured":"Wang Y Sun Y Yang B Li J Liang C. 2024. The effect and mechanism of liraglutide on the biological functions of BMSCs in diabetic patients. Oral Dis. 30(8):5160\u20135174. https:\/\/doi.org\/10.1111\/odi.14931","DOI":"10.1111\/odi.14931"},{"key":"e_1_3_4_38_1","doi-asserted-by":"crossref","unstructured":"Wilding JPH et al. 2021. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 384(11):989\u20131002. https:\/\/doi.org\/10.1056\/nejmoa2032183","DOI":"10.1056\/NEJMoa2032183"},{"key":"e_1_3_4_39_1","doi-asserted-by":"crossref","unstructured":"Xu Y Zheng J Liu M Fu Z Wang P. 2025. Exendin-4 reduces senescence of inflammation-induced periodontal ligament stem cells through SIRT1\/Notch1 signaling. Stem Cells Int. 2025:7639451. https:\/\/doi.org\/10.1155\/sci\/7639451","DOI":"10.1155\/sci\/7639451"},{"key":"e_1_3_4_40_1","doi-asserted-by":"crossref","unstructured":"Yang M et al. 2022. Therapeutic potential of liraglutide for diabetes-periodontitis comorbidity: killing two birds with one stone. J Diabetes Res. 2022:8260111. https:\/\/doi.org\/10.1155\/2022\/8260111","DOI":"10.1155\/2022\/8260111"}],"container-title":["Journal of Dental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00220345261488338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00220345261488338","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00220345261488338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:19:33Z","timestamp":1792153173000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00220345261488338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":39,"alternative-id":["10.1177\/00220345261488338"],"URL":"https:\/\/doi.org\/10.1177\/00220345261488338","relation":{},"ISSN":["0022-0345","1544-0591"],"issn-type":[{"value":"0022-0345","type":"print"},{"value":"1544-0591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"article-number":"00220345261488338"}}